Then sell fast!
Oh wait, you're not long Nokia because it's all hype?
Then why are you bashing?
Your on ignore from hereon in.
I suggest everyone else do the same to you and the likes of everyone like you.
To this day I don't understand why no one bought the entire company!
MSFT could have had the phone business, HERE mapping, and all the patents!
...but god forbid you want to post a legitimate article on the company!
Can't do it.
Wish someone could develop and move all our postings to a new message board not affiliated with Yahoo.
Came thru on Scottrade newswire.
Yahoo won't let me post it.
Simply said just what you stated: Nokia will surprise everyone with something big!
ALU management knows their days are numbered. The CEO said as much.
Otherwise, why would they be so desperate to merge with Nokia?
Think people, think!
No merger.....no more ALU.
All this talk by hedge funds not willing to tender their shares is simply a ploy to garner a better deal.
Sentiment: Strong Buy
Earlier this morning (May 28, 2015), Soligenix (SNGX) announced a collaboration agreement with Dr. Axel Lehrer from John A. Burns School of Medicine (JABSOM), University of Hawai and Hawaii Biotech, Inc. (HBI) to develop a heat stable subunit Ebola vaccine.
Dr. Lehrer is a co-inventor of the Ebola vaccine with HBI, which has shown proof of concept efficacy with subunit Ebola vaccines in non-human primates. Under the terms of the feasibility agreement, Soligenix will evaluate its proprietary vaccine thermostabilization technology, ThermoVax™, to stabilize components of the vaccine. Ultimately, the objective is to produce a thermostable Ebola vaccine for worldwide distribution that does not require cold storage, yielding a vaccine ideal for use in both the developed and developing world.
ThermoVax™ has been previously demonstrated to enhance thermostability of both ricin (RiVax™) and anthrax (VeloThrax™) subunit vaccines. The initial work on the potential Ebola vaccine will focus on a single protein subunit antigen.
The collaboration on Ebola vaccine development further expands Soligenix’ ThermoVax™ technology.
Financial terms were not disclosed, but we believe Soligenix may get milestone and royalty payment if the vaccine is successfully developed.
SNGX will work with University in collaboration on a potential eboli vaccine to make is shelf stable, for worldwide distribution. So far the vaccine has proven it's efficacy in primates.
The article states that SNGX could receive royalties and milestone payments from this procedure, which was originally developed for Ricin and Anthrax.
This is GREAT news.
Forget the stock price. Just follow the developments and you'll be justly rewarded.
Doubt the shorts are panicking just yet.
Volume isn't there.
But when they do throw in towel, we could see a $10-$20 pop in share price in one day
Not if Carl Icahn has anything to say about it.
He want Apple to buy back even more shares than they proposed.
Probably wants to unload his holdings on them as ZeroHedge claims in an article. Unloading his massive stake in the market could tank the stock.
Nokia holds the trump card.
They will not sell, nor need to, for any price below $8 billion.
I submitted a proposal to Nokia that would have Here generate $8 billion in net profit yearly!
I would welcome anyone to join me with any law enforcement contacts.